(Q24243292)

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Clomipramine and Amitriptyline in the Treatment of Severe Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Psychogenic facial pain: presentation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Traitement des douleurs post-zostériennes par le tramadol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

St. John's wort has no effect on pain in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Venlafaxine in neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Depression masquerading as diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Peripheral Diabetic Neuropathy Treated With Amitriptyline and Fluphenazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Analgesic and antidepressive effects of low-dose amitriptyline in relation to its metabolism in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

The Effects of Antidepressant Drugs on Pain Relief and Mood in the Chronically Ill: A Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Diabetic peripheral neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Clomipramine and mianserin in chronic idiopathic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Low dose amitriptyline in the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Dose-response for analgesic effect of amitriptyline in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Amitriptyline treatment of chronic pain in patients with temporomandibular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Efficacy of sustained-release bupropion in neuropathic pain: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Changes in the augmenter-reducer tendency and in pain measures as a result of treatment with a serotonin-reuptake inhibitor--zimelidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Low dose amitriptyline in chronic pain: the gain is modest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

The use of antidepressants in the treatment of chronic pain. A review of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Pharmacological management of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

Treatment of painful diabetic neuropathy with trazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Trazodone for deafferentation pain. Comparison with amitriptyline.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Lack of effect of mianserin on the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Psychogenic facial pain: Presentation and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

A controlled study of amitriptyline in the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

The analgesic effect of amitriptyline on chronic facial pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

A controlled study of psychotherapy and amitriptyline used individually and in combination in the treatment of chronic intractable, 'psychogenic' pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Out-patient cognitive-behavioural therapy with amitriptyline for chronic non-malignant pain: a comparative study with 6-month follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Psychogenic facial pain. Part 1: The clinical presentation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Psychogenic facial pain. Part 2: Management and prognosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Clinical trial of amitriptyline and fluphenazine in diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Mianserin and chronic pain: a double-blind placebo-controlled process and outcome study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

An Open and Double-Blind Cross-Over Study on the Efficacy of Clomipramine (Anafranil®) in Patients with Painful Mono- and Polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Atypical facial pain and depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

The effect of L-tryptophan supplementation and dietary instruction on chronic myofascial pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005454.PUB2

7 January 2021

10.1002/14651858.CD005454.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_2mcuerlm7fgzfgu7cpydgi6bua

538491

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2mcuerlm7fgzfgu7cpydgi6bua

24 November 2022

mapped directly with Wikidata item

538491

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference